Could a common drug shrink birth defects in kids?
NCT ID NCT03243019
First seen Jan 05, 2026 · Last updated May 10, 2026 · Updated 19 times
Summary
This study tests the drug rapamycin in children with severe lymphatic malformations in the head and neck area that cannot be safely removed with surgery. The goal is to see if taking rapamycin for 6 months can shrink these growths by at least one-fifth and improve symptoms like pain, breathing, and swallowing. The trial involves 28 children up to 18 years old.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hu Robert Debre Aphp - Paris
RECRUITINGParis, France
-
Hôpital Jeanne de Flandres, CHU
RECRUITINGLille, France
Contact
Conditions
Explore the condition pages connected to this study.